Disease-Type-Aware Biological Intelligence Layers for Preventing Symptom Marker False Positives in Computational Drug Target Identification

Read full text Summarise with VIRAT
Authors: Kelyn Paul Njeri
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Three-layer biological intelligence system: disease-type-aware target classifier (9 gene families, 119+ genes, 6-step pipeline), tissue expression boolean gate (Human Protein Atlas), and known-target validator. Prevents symptom markers (GABA receptors, ion channels, inflammatory cytokines) from being promoted as drug targets in infectious diseases while preserving them for autoimmune/neurodegenerative contexts. Mean F₁ = 0.474, zero false positives across 7 diseases.

Fields of Study & Subjects

Computational Drug Discovery Methods Bioinformatics and Genomic Networks Biomedical Text Mining and Ontologies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
31 March 2026
Language
EN
Document type
Preprint